Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2011 1
2012 1
2013 2
2014 4
2015 3
2016 4
2017 4
2018 7
2019 6
2020 8
2021 14
2022 5
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean sung hoon kim (1,296 results)?
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.
Application of cancer genomics to solve unmet clinical needs.
Lee SH, Sim SH, Kim JY, Cha S, Song A. Lee SH, et al. Among authors: sim sh. Genomics Inform. 2013 Dec;11(4):174-9. doi: 10.5808/GI.2013.11.4.174. Epub 2013 Dec 31. Genomics Inform. 2013. PMID: 24465227 Free PMC article. Review.
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients With ERBB2-Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial.
Ahn HK, Sim SH, Suh KJ, Kim MH, Jeong JH, Kim JY, Lee DW, Ahn JH, Chae H, Lee KH, Kim JH, Lee KS, Sohn JH, Choi YL, Im SA, Jung KH, Park YH. Ahn HK, et al. Among authors: sim sh. JAMA Oncol. 2022 Sep 1;8(9):1271-1277. doi: 10.1001/jamaoncol.2022.2310. JAMA Oncol. 2022. PMID: 35797012 Free PMC article. Clinical Trial.
Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1).
Imoto S, Wang K, Bi XW, Liu G, Im YH, Im SA, Sim SH, Ueno T, Futamura M, Toi M, Fujiwara Y, Ahn SG, Lee JE, Park YH, Takao S, Oba MS, Kitagawa Y, Nishiyama M. Imoto S, et al. Among authors: sim sh. Breast Cancer. 2023 May;30(3):412-423. doi: 10.1007/s12282-023-01436-7. Epub 2023 Jan 23. Breast Cancer. 2023. PMID: 36689066
Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study.
Kang D, Kim S, Kim H, Lee M, Kong SY, Chang YJ, Sim SH, Kim YJ, Cho J. Kang D, et al. Among authors: sim sh. JMIR Public Health Surveill. 2023 Mar 8;9:e44105. doi: 10.2196/44105. JMIR Public Health Surveill. 2023. PMID: 36884274 Free PMC article.
Comprehensive somatic genome alterations of urachal carcinoma.
Lee S, Lee J, Sim SH, Lee Y, Moon KC, Lee C, Park WY, Kim NK, Lee SH, Lee H. Lee S, et al. Among authors: sim sh. J Med Genet. 2017 Aug;54(8):572-578. doi: 10.1136/jmedgenet-2016-104390. Epub 2017 Mar 27. J Med Genet. 2017. PMID: 28348108
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort Study.
Koo DH, Lee KS, Sim SH, Chae H, Lee EG, Han JH, Jung SY, Lee S, Kang HS, Lee ES, Park CY, Oh SW. Koo DH, et al. Among authors: sim sh. Breast Cancer (Dove Med Press). 2023 Apr 14;15:251-261. doi: 10.2147/BCTT.S406685. eCollection 2023. Breast Cancer (Dove Med Press). 2023. PMID: 37081941 Free PMC article.
Updated results from the international phase III ALTTO trial (BIG 2-06/Alliance N063D).
Moreno-Aspitia A, Holmes EM, Jackisch C, de Azambuja E, Boyle F, Hillman DW, Korde L, Fumagalli D, Izquierdo MA, McCullough AE, Wolff AC, Pritchard KI, Untch M, Guillaume S, Ewer MS, Shao Z, Sim SH, Aziz Z, Demetriou G, Mehta AO, Andersson M, Toi M, Lang I, Xu B, Smith IE, Barrios CH, Baselga J, Gelber RD, Piccart-Gebhart M; ALTTO Steering Committee and Investigators. Moreno-Aspitia A, et al. Among authors: sim sh. Eur J Cancer. 2021 May;148:287-296. doi: 10.1016/j.ejca.2021.01.053. Epub 2021 Mar 23. Eur J Cancer. 2021. PMID: 33765513 Free PMC article. Clinical Trial.
62 results